US 12,325,698 B2
Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same
In Hwan Bae, Hwaseong-Si (KR); Ji Sook Kim, Hwaseong-Si (KR); Jae Yul Choi, Hwaseong-si (KR); Seok Jong Kang, Hwaseong-si (KR); Young Gil Ahn, Hwaseong-si (KR); and Kwee Hyun Suh, Hwaseong-si (KR)
Assigned to Hanmi Pharm. Co., Ltd., Hwaseong-Si (KR)
Filed by Hanmi Pharm. Co., Ltd., Hwaseong-Si (KR)
Filed on Jan. 25, 2022, as Appl. No. 17/583,841.
Application 16/859,413 is a division of application No. 16/396,233, filed on Apr. 26, 2019, granted, now 10,870,639, issued on Dec. 22, 2020.
Application 17/583,841 is a continuation of application No. 16/859,413, filed on Apr. 27, 2020, granted, now 11,292,786.
Application 16/396,233 is a continuation of application No. PCT/KR2019/001737, filed on Feb. 13, 2019.
Claims priority of application No. 10-2018-0086768 (KR), filed on Jul. 25, 2018.
Prior Publication US 2023/0002358 A1, Jan. 5, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 403/14 (2006.01); A61P 35/02 (2006.01); A61K 31/4025 (2006.01); A61K 31/506 (2006.01)
CPC C07D 403/14 (2013.01) [A61P 35/02 (2018.01); A61K 31/4025 (2013.01); A61K 31/506 (2013.01)] 8 Claims
 
1. A compound selected from:

OG Complex Work Unit Chemistry
a stereoisomer thereof, or a mixture of stereoisomers thereof,
or a pharmaceutically acceptable salt and/or solvate thereof.